Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro

Chinese Medical Journal

Volumn 118, Issue 6, 2005, Pages 493-496

  Zhang, Chuan Hai ^a   Wang, Yi Fei ^b   Liu, Xin Jian ^b   Lu, Jia Hai ^c   Qian, Chui Wen ^b   Wan, Zhuo Yue ^d   Yan, Xin Ge ^d   Zheng, Huan Ying ^d   Zhang, Mei Ying ^b   Xiong, Sheng ^b   Li, Jiu Xiang ^b   Qi, Shu Yuan ^e  

^a WEST ANHUI UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e SOUTH CHINA INSTITUTE OF BOTANY   (China)

Author keywords

Antiviral activity; Cepharanthine; Coronarivus; Severe acute respiratory syndrome

Indexed keywords

ANTIVIRUS AGENT; CEPHARANTHINE; VIRUS VACCINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG DETERMINATION; EPIDEMIC; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION CONTROL; INFECTION PREVENTION; MONOLAYER CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STEPHANIA; VERO CELL; VIRUS CULTURE; VIRUS STRAIN;

ALKALOIDS; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; SARS VIRUS; VERO CELLS;

EID: 20144387814     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Zhang CH, Wang YF, Zhang MY, et al. Recent progress in the studies on SARS and its pathogeny. Chin Bull Life Sci (Chin) 2003;15:129-133.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976.
3. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300: 1394-1399.
4. Zhang CH, Guo ZM, Zheng HY, et al. Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain. Chin Med J 2004;117:1625-1629.
5. Chen F, Chan KH, Jiang Y, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004;31:69-75.
6. The Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004;303:1666-1669.
7. Ruan YJ, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003; 361: 1779-1787.
8. Wang YF, Liu XJ, Zhang MY, et al. Testing drug sensitivity of cells by MTS/PMS. Chin J Health Lab Technol (Chin) 2003;13:146-147.
9. Reed LJ, Muench H. A simple method for estimating fifty percent end points. Am J Hyg 1938;27:493-497.
10. Liu XJ, Wang YF, Zhang MY, et al. Study on the inhibitory effect of cepharanthine on herpes simplex type 1 virus (HSV-1) in vitro. J Chin Medicinal Mater (Chin) 2004;27:107-110.